Luigi Mangione pleads guilty to federal stalking charges in the killing of UnitedHealthcare CEO
In pleading guilty, Mangione admitted to following UnitedHealth executive Brian Thompson and then shooting him.
Read full article →Healthcare Policy
Latest Healthcare Policy news from across the web.
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read full article →STAT+: PBMs agree to display TrumpRx drug prices
Bristol's Zenbexus wins accelerated approval, Novartis wins UK patent fight over Entresto, and more biotech news from The Readout
Read full article →STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer
Read full article →STAT+: Drug-testing lab that has sparked controversy sues group that develops drug standards over criticism
A lab that tussled with regulators over impurities found in widely used medicines has accused U.S. Pharmacopeia of making false and misleading remarks about its methods.
Read full article →Is there a summer COVID-19 surge this year? Yep, it's ramping up again
Just like all previous summers since the pandemic began, COVID-19 cases are ticking up again, even while other health threats make more headlines.
Read full article →The Taliban has taken a terrible toll on the education of girls -- and boys as well
Saturday marks the 5th anniversary of the current Taliban rule in Aghanistan. They've had a devastating impact on girls' education. A lesser told story is their impact on the education of boys.
Read full article →STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.
Read full article →How will legal challenges fare against CMS rule on gender-affirming care?
A CMS rule finalized this week may prove more difficult to challenge than previous Trump administration actions to end transgender care for young people.
Read full article →Opinion: MAHA and insurance companies both want to treat human bodies like cars
“If the short history of telematics in the auto insurance taught us anything, it’s to be skeptical of any promises attached to shareable surveillance data.”
Read full article →Two years after rules overhaul, have methadone clinics really changed?
Methadone clinics don't have to be as rigid in how they dispense opioid addiction medicine. Some, though not all, are changing their ways.
Read full article →Opinion: U.S., U.K. health care systems share a fatal flaw
“The default to biomedical responses means that clinics and hospitals are increasingly absorbing the costs of social problems,” writes Kyle Vanelli.
Read full article →